Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iovance Biotherapeutics (IOVA) Other Non-Current Liabilities: 2011-2019

Historic Other Non-Current Liabilities for Iovance Biotherapeutics (IOVA) over the last 1 years, with Sep 2019 value amounting to $53,000.

  • Iovance Biotherapeutics' Other Non-Current Liabilities was N/A to $53,000 in Q3 2019 from the same period last year, while for Sep 2019 it was $53,000, marking a year-over-year change of. This contributed to the annual value of $230,000 for FY2018, which is N/A change from last year.
  • Per Iovance Biotherapeutics' latest filing, its Other Non-Current Liabilities stood at $53,000 for Q3 2019, which was down 0.00% from $53,000 recorded in Q2 2019.
  • Over the past 5 years, Iovance Biotherapeutics' Other Non-Current Liabilities peaked at $230,000 during Q4 2018, and registered a low of $53,000 during Q1 2019.
  • Over the past 2 years, Iovance Biotherapeutics' median Other Non-Current Liabilities value was $53,000 (recorded in 2019), while the average stood at $97,250.